arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Gilead Sciences, Inc.

GILD Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$129.16
▼ -0.0% Today
as of Jun 7, 07:16 ET
Last 30 days -0.08% Apr 28 → Jun 05
$126.87 $129.40 $131.94 $134.47 $137.00 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$130.09
High
$131.66
Low
$128.92
Volume
$13M
Avg Vol
$7M
Mkt Cap
$169.1B
P/E (TTM)
23.06
Beta
52w High
$157.29
52w Low
$104.46
Div Yield
Shares Out
$1.2B

Overview

52-week range
$104
$157
47% of range
Avg surprise (last 2)
+3.4%
Avg reaction (last 2)
-0.9%
0% positive
Latest IV / EM
34%
EM ±3.2% · $129 · Jun 12

Earnings trends

EPS — actual vs estimate Actual Estimate
$-3.34$-1.90$-0.46$0.99$2.43 Actual $0.83Actual $1.73Actual $-3.34Actual $1.29Actual $1.00Actual $1.81Est $1.82Actual $1.56Actual $2.43Actual $2.03Est $1.89 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$0$801M$1.6B$2.4B$3.2B Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $2.03 $1.89 +7.4% +12.2% -1.6% earnings
Tue Sep 30, 2025Sep 2025 $2.43 financials
Mon Jun 30, 2025Jun 2025 $1.56 financials
Thu Apr 24, 2025Mar/2025 $1.81 $1.82 -0.6% -0.2% earnings
Mon Sep 30, 2024Sep 2024 $1.00 financials
Sun Jun 30, 2024Jun 2024 $1.29 financials
Sun Mar 31, 2024Mar 2024 $-3.34 financials
Sat Sep 30, 2023Sep 2023 $1.73 financials
Fri Jun 30, 2023Jun 2023 $0.83 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$1.45B$1.57B$1.50B$1.54B$1.57B$1.54B
Gross profit
Operating income$2.59B$3.33B$2.47B$2.24B$888M$2.64B
Net income$2.02B$3.05B$1.96B$1.31B$1.25B$1.61B
EPS (diluted)$1.61$2.43$1.56$1.04$1.00$1.29

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents
Inventory$1.91B$1.77B$1.78B$1.82B$1.76B$1.71B$1.87B$2.03B
Total current assets$18.64B$18.34B$17.87B$14.72B$16.90B$19.17B$14.78B$12.32B
Total assets$56.28B$59.02B$58.53B$55.72B$56.43B$58.99B$54.52B$53.58B
Long-term debt$20.86B$22.13B$22.14B$22.14B$22.15B$24.90B$21.44B$21.54B
Total liabilities
Total equity$23.52B$22.70B$21.54B$19.67B$19.16B$19.33B$18.48B$18.28B

Implied volatility — last 90 days

29%31%34%36%39% Jun 07 — IV 34% · EM ±3.2%

Sector peers